Prompt Provides Men the Ability to Make Informed Decisions About Their Health
Despite being curable with early detection, prostate cancer remains the second leading cause of cancer deaths in men.1 Due to controversial recommendations about the common screening tool, called PSA, early detection rates and prostate cancer screenings are declining. At the same time, the number of men with incurable disease is on the rise. 2,3
Regular screening has been recommended if you are at high risk — but how do you know your individual risk? Relying on family history alone may not be enough.
Prompt® was designed to provide men, along with their families and clinicians, with the knowledge to make informed decisions about their health.
Prompt is currently validated only in Caucasian men, though testing for additional ethnic origins is in development.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a cancer journal for clinicians. 2018;68(1):7-30.
2. Gaylis FD, Choi J, Kader AK. Trends in Metastatic Breast and Prostate Cancer. The New England journal of medicine. 2016;374(6):594-5.
3. Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 2018;124(13):2801-14.
Collecting A Sample
Swab Inside of Cheek
Secure swab in tube
Our genetic test encourages men to be actively involved in the development of their personalized prostate cancer screening approach at an early stage. With a simple cheek swab, Prompt® compares your specific genetic profile to tens of thousands of others and can help you and your physician determine what is best for you.
Prompt will empower you and your doctor with your genetic score to make an informed decision about screening.
Knowledge is power… Ask your doctor about your Prompt Prostate Genetic Score today.